Tag Archives: EvaluatePharma

Pharma R&D Pipeline Value Jumps 18 Percent to $493 Billion

World Preview 2015, Outlook to 2020

The pharmaceutical industry continues its impressive two-year growth with no signs of slowing down according to new consensus forecast data from the annual state of the industry report, “World Preview 2015, Outlook to 2020” from market intelligence firm, Evaluate. The report, which launched today at the 2015 BIO International Convention, found that worldwide prescription drug sales are expected to grow at 4.8 percent a year until 2020 – growth that is being fueled by the Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Worldwide Prescription Drug Sales to Exceed Trillion Dollar Mark by 2020

20140618_World_Preview_DNA_Infographic_JW

The pharmaceutical industry will top the one trillion dollar mark by 2020, according to new consensus forecast data found in the annual state of the industry report,  “World Preview 2014, Outlook to 2020” from market intelligence firm, Evaluate. The report, which launched today at the 2014 BIO international Convention, finds that worldwide prescription drug sales will reach $1,107 bn by 2020. This milestone is particularly pertinent as it proves that after two years of sales Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Industry Growth Factor: Biologics

Graph

Last week, EvaluatePharma released their updated sales and R&D outlook for the drug industry in their report “World Preview 2013, Outlook to 2018”. Among the 37 pages of data, one central take home message was that growth will return to the sector after a small dip in 2012. Behind this predicted comeback in sales growth is the rise of biologics products that continue to gain a larger percentage of total revenue. Consider the data below taken from Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,